Literature DB >> 9740019

Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal.

J W Russell1, A J Windebank, A Schenone, E L Feldman.   

Abstract

Insulin-like growth factor-I (IGF-I) is emerging as an important growth factor able to modulate the programmed cell death (PCD) pathway mediated by the cysteine-dependent aspartate proteases (caspases); however, little is known about the effect of IGF-I after nerve growth factor (NGF) withdrawal in neurons. To begin to understand the neuronal death-sparing effect of IGF-I under NGF-free conditions, we tested whether embryonic sensory dorsal root ganglion neurons (DRG) were able to survive in defined serum-free medium in the presence of IGF-I. We further studied the role of IGF-I signaling and caspase inhibition after NGF withdrawal. NGF withdrawal produced histological changes of apoptosis including chromatin condensation, shrinkage of the perikaryon and nucleus, retention of the plasma membrane, and deletion of single cells. Both IGF-I and Boc-aspartyl (OMe)-fluoromethylketone (BAF), a caspase inhibitor, equally reduced apoptosis after NGF withdrawal. The antiapoptotic effect of IGF-I was completely blocked by LY294002, an inhibitor of PI 3-kinase signaling, but not by the mitogen-activated protein (MAP) kinase/extracellular signal-regulated protein kinase (ERK) activated protein kinase inhibitor PD98059. Functional IGF-I receptors were extensively expressed both in rat and human DRG neurons, although they were most abundant in the neuronal growth cone. Collectively, these findings indicate that IGF-I, signaling though the PI-3 kinase pathway, is important in modulating PCD in cultured DRG neurons after NGF withdrawal, and IGF-I may be important in DRG embryogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740019     DOI: 10.1002/(sici)1097-4695(19980915)36:4<455::aid-neu1>3.0.co;2-v

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  22 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro.

Authors:  Andrea M Vincent; Eva L Feldman; Debbie K Song; Verena Jung; Andreas Schild; Wei Zhang; Michael J Imperiale; Nicholas M Boulis
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

3.  Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice.

Authors:  J A Christianson; J M Ryals; M S Johnson; R T Dobrowsky; D E Wright
Journal:  Neuroscience       Date:  2006-12-16       Impact factor: 3.590

4.  Effects of electro-acupuncture on IGF-I expression in spared dorsal root ganglia and associated spinal dorsal horn in cats subjected to adjacent dorsal root ganglionectomies.

Authors:  Ping Dai; Zhao-Jun Wang; Wei-wei Sun; Jiang-xia Pang; Chao You; Ting-Hua Wang
Journal:  Neurochem Res       Date:  2009-05-22       Impact factor: 3.996

Review 5.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

6.  The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons.

Authors:  Joseph M Corey; Caitlyn C Gertz; Bor-Shuen Wang; Lisa K Birrell; Sara L Johnson; David C Martin; Eva L Feldman
Journal:  Acta Biomater       Date:  2008-03-12       Impact factor: 8.947

Review 7.  Biomarkers in Alzheimer's disease: past, present and future.

Authors:  Katarzyna Gustaw-Rothenberg; Alan Lerner; David J Bonda; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 8.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

9.  PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.

Authors:  Arnulfo Quesada; Becky Y Lee; Paul E Micevych
Journal:  Dev Neurobiol       Date:  2008-04       Impact factor: 3.964

Review 10.  IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Authors:  Raffael Liegl; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Early Hum Dev       Date:  2016-09-17       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.